Track topics on Twitter Track topics that are important to you
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Ma...
Flybridge Capital Partners led the funding round, and Fusion Fund, Emerald Development Managers, Razor’s Edge Ventures and Robin Hood Ventures also participated.
Accelerates advancement of AI-enhanced digital pathology to improve cancer diagnosis and outcomes Proscia, the pioneer in the development and advancement of d...
Merging of technologies will help pathologists and doctors give more effective prognostic assessments than current standard of care TORONTO (PRWEB) April 10, 2018 Proscia Inc., creators of AI-powered...
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery o...
We have published hundreds of Proscia Inc. news stories on BioPortfolio along with dozens of Proscia Inc. Clinical Trials and PubMed Articles about Proscia Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proscia Inc. Companies in our database. You can also find out about relevant Proscia Inc. Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...